<DOC>
	<DOCNO>NCT01166243</DOCNO>
	<brief_summary>The objective study evaluate safety hemostatic effectiveness Fibrin Pad ( FP ) versus standard care treatment ( SoC ) control parenchymal bleed hepatic surgery .</brief_summary>
	<brief_title>The Fibrin Pad Liver Study</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>Subjects &gt; 18 year age , require elective urgent , open hepatic surgery Presence appropriate bleed hepatic parenchymal Target Bleeding Site ( TBS ) identify intraoperatively surgeon Subjects must willing participate study , provide write informed consent Subjects intraoperative finding identify surgeon may preclude conduct study procedure TBS large defect artery vein injure vascular wall require repair maintenance vessel patency would result persistent exposure FP blood flow pressure heal absorption product TBS major arterial bleed require suture mechanical ligation Subjects admit trauma surgery Subject transplant patient fulminant hepatic failure Subject TBS within actively infected field Bleeding site , around , proximity foramen bone , area bony confine Subjects know intolerance blood product one component study product unwilling receive blood product Subjects know , current alcohol / drug abuser Subjects participate another investigational drug device research study within 30 day surgery Female subject pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Hemostasis</keyword>
</DOC>